What it's for (Indications)
- Chlorpheniramine maleate is indicated for the symptomatic relief of allergic conditions mediated by histamine, including seasonal and perennial allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis.
- It is also utilized for the amelioration of uncomplicated allergic skin manifestations of urticaria and angioedema.
- Furthermore, it serves as an adjunctive therapy to epinephrine and other standard measures in the treatment of anaphylactic reactions.
- Its effectiveness extends to alleviating symptoms of the common cold such as sneezing and rhinorrhea.
- This medication provides systemic relief from acute and chronic allergic reactions by counteracting the effects of histamine, thereby reducing inflammation and associated discomfort.
- The breadth of its application underscores its utility in managing a variety of allergic presentations, offering respite from symptoms like pruritus, rhinorrhea, and ocular irritation.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of chlorpheniramine maleate must be individualized based on patient age, weight, and clinical response, always adhering to recommended maximum daily limits. For adults and children 12 years of age and older, the typical oral dose is 4 mg every 4 to 6 hours, not exceeding 24 mg in a 24-hour period. For children 6 to 11 years of age, the recommended dose is 2 mg every 4 to 6 hours, with a maximum daily dose of 12 mg. Children 2 to 5 years of age typically receive 1 mg every 4 to 6 hours, not to exceed 6 mg per day. The medication is not generally recommended for infants under 2 years of age without explicit guidance from a healthcare professional due to potential risks and lack of established safety and efficacy. Administration should be with food or milk if gastrointestinal upset occurs to minimize irritation. It is crucial to use an accurate measuring device for liquid formulations to ensure precise dosing and prevent accidental overdose. |
Safety & Warnings
Common Side Effects
- The most frequently reported side effects associated with chlorpheniramine maleate are dose-related and include central nervous system (CNS) depression, manifesting as drowsiness, sedation, and dizziness, which can significantly impair mental and physical abilities required for driving or operating machinery.
- Anticholinergic effects are also common, presenting as dry mouth, blurred vision, urinary retention, and constipation.
- Gastrointestinal disturbances such as nausea, vomiting, epigastric distress, and diarrhea may occur.
- Less common side effects include nervousness, excitability (particularly in children, sometimes paradoxical), insomnia, tremors, headache, and fatigue.
- Rarely, serious adverse effects such as blood dyscrasias (e.
- g.
- , agranulocytosis, hemolytic anemia), cardiovascular effects (e.
- g.
- , palpitations, tachycardia, arrhythmias), and severe allergic reactions have been reported.
- Patients experiencing severe or persistent side effects should seek immediate medical attention and discontinue use.
Serious Warnings
- Black Box Warning: **Serious Warnings Regarding Chlorpheniramine Maleate Use:** While chlorpheniramine maleate does not carry a formal FDA Black Box Warning, it is imperative for healthcare professionals and patients to be aware of several significant safety concerns, particularly regarding its central nervous system (CNS) depressant and anticholinergic effects. This medication can cause profound drowsiness and impaired cognitive and motor function, significantly increasing the risk of accidents when performing tasks requiring mental alertness, such as driving or operating heavy machinery. Concomitant use with alcohol or other CNS depressants, including sedatives, hypnotics, tranquilizers, and other antihistamines, can lead to severe potentiation of sedation, respiratory depression, and potentially life-threatening CNS depression. Additionally, its anticholinergic properties pose risks, especially in elderly patients who are more susceptible to confusion, delirium, urinary retention, and constipation. Pediatric patients, conversely, may experience paradoxical excitation. Patients with pre-existing conditions such as glaucoma, prostatic hypertrophy, or gastrointestinal obstruction should use this medication with extreme caution or avoid it entirely, as anticholinergic effects can exacerbate these conditions.
- Chlorpheniramine maleate should be used with extreme caution in patients with conditions that may be exacerbated by anticholinergic effects, such as narrow-angle glaucoma, prostatic hypertrophy, bladder neck obstruction, pyloroduodenal obstruction, or stenosing peptic ulcer.
- Patients with cardiovascular disease, including hypertension and ischemic heart disease, hyperthyroidism, and bronchial asthma, should also be monitored closely, as anticholinergic effects can worsen these conditions.
- Due to its potential for CNS depression, patients should be warned against engaging in activities requiring complete mental alertness, such as driving a motor vehicle or operating hazardous machinery, until the individual response to the drug is known.
- Concomitant use with alcohol or other CNS depressants can significantly potentiate sedative effects.
- Elderly patients are particularly susceptible to the sedative and anticholinergic side effects and may experience increased confusion, dizziness, and hypotension, necessitating careful dosage adjustment.
- Paradoxical excitation, characterized by restlessness, insomnia, and tremors, can occur, especially in young children and should prompt discontinuation.
How it Works (Mechanism of Action)
Chlorpheniramine maleate functions primarily as a potent, competitive histamine H1 receptor antagonist. By binding to H1 receptors located on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract, it effectively blocks the action of endogenous histamine. This blockade prevents histamine from eliciting its characteristic effects, which include vasodilation, increased capillary permeability, itching, and contraction of bronchial smooth muscle. Consequently, chlorpheniramine reduces symptoms such as sneezing, rhinorrhea, pruritus, and watery eyes associated with allergic reactions. Additionally, chlorpheniramine possesses significant anticholinergic activity, blocking muscarinic receptors. This anticholinergic effect contributes to some of its therapeutic actions, such as reducing nasal secretions, but also accounts for many of its common side effects like dry mouth and blurred vision. Its lipophilicity allows it to cross the blood-brain barrier, leading to its characteristic sedative effects, making it a first-generation antihistamine.
Commercial Brands (Alternatives)
No other brands found for this formula.